Professional Documents
Culture Documents
Morphine (Astramorph) PCA
Morphine (Astramorph) PCA
Why is your patient getting this medication For IV meds, compatibility with IV drips and/or
Sever pain solutions
Rate: administer via infusion pump to control the rate.
Dose should be titrated to ensure adequate pain relief /s
excessive sedation, respiratory depression, or hypotension.
Interactions with other patient drugs, OTC or Lab value alterations caused by medicine
herbal medicines (ask patient specifically) May ↑ plasma amylase and lipase levels
None for this patient
Be sure to teach the patient the following about this
medication
Instruct patient how and when to ask for pain medication. May cause
drowsiness or dizziness. Caution patient to call for assistance when
ambulating. Advise patient tEncourage patients who are immobilized
or on prolonged bedrest to turn, cough, and breathe deeply every 2 hr
to prevent atelectasiso change positions slowly to minimize orthostatic
hypotension.
Nursing Process- Assessment Assessment Evaluation
(Pre-administration assessment) Why would you hold or not give this Check after giving
Assess type, location, and intensity of pain prior to med? Decrease in severity of pain
and 20 min (peak) following IV administration. Assess level of consciousness, blood pressure, without a significant alteration in
Assess bowel function routinely. Ask about pulse, and respirations before and periodically level of consciousness or
breakthrough pain during administration. If respiratory rate is respiratory status.
<10/min, assess level of sedation. Physical
stimulation may be sufficient to prevent
significant hypoventilation. Subsequent doses
may need to be decreased by 25-50%. Initial
drowsiness will diminish with continued.
Toxicity and Overdose: If an opioid
antagonist is required to reverse respiratory
depression or coma, naloxone (Narcan) is the
antidote.